NCT02504918View on ClinicalTrials.gov

Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian Children

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

July 21, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

June 12, 2018

Conditions

Malaria

Trial Locations (1)

Unknown

Ouelessebougou Clinical Research Center MRTC/ FMPOS, Wolossébougou

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02504918 - Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian Children | Biotech Hunter | Biotech Hunter